Statistics

Total Visits

Views
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 1025

Total Visits per Month

August 2025 September 2025 October 2025 November 2025 December 2025 January 2026 February 2026
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 28 26 19 21 14 18 5

File Downloads

Views
Kyriazopoulou.pdf 436

Top Country Views

Views

Top City Views

Views